BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang CJ, Chiu CT, Yeh YC, Chao A. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report. World J Clin Cases 2022; 10(2): 625-630 [PMID: 35097088 DOI: 10.12998/wjcc.v10.i2.625]
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/625.htm
Number Citing Articles
1
Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazaki. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic WithdrawalCureus 2023;  doi: 10.7759/cureus.47088
2
Haloperidol/lorazepamReactions Weekly 2022; 1894(1): 165 doi: 10.1007/s40278-022-10278-2
3
Jing Zhao, Wei-Bo Wang, Hui Ding, Hua-Jun Fu, Yan-An Jiang, Zhiqian Zhang. Prevention of Dexmedetomidine on Postoperative Delirium and Early Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic LobectomyEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5263021
4
Ken Shimada, Yutaro Kase, Makoto Nakatsuru, Hideki Tanzawa. Neuroleptic malignant syndrome in fields other than psychiatryOral Science International 2023; 20(3): 165 doi: 10.1002/osi2.1171